Medication overuse headaches - What is new?

Expert Opinion on Drug Safety

Volumn 1, Issue 4, 2002, Pages 331-338

  Fritsche, Guenther ^a   Diener, Hans Christoph ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

drug induced headache; medication overuse headache; migraine; tension type headache; withdrawal therapy

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

CHEMICALLY INDUCED DISORDER; CLASSIFICATION; EXPERT WITNESS; HEADACHE AND FACIAL PAIN; HUMAN; MIGRAINE; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; REVIEW; WITHDRAWAL SYNDROME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EXPERT TESTIMONY; HEADACHE DISORDERS; HUMANS; MIGRAINE DISORDERS; PREVALENCE; PROGNOSIS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0042736548     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.1.4.331     Document Type: Review

References (52)

1. DICHGANS J, DIENER HC: Clinical manifestations of excessive use of analgesic medication. In: Drug-induced headache. Diener HC, Wilkinson M (Eds), Springer, Berlin (1988):8-15.
2. NO AUTHORS LISTED: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia (1988) 8(7):1-93.
3. EVERS S, SUHR B, BAUER B, GROTEMEYER KH, HUSSTEDT IW: A retrospective long-term analysis of the epidemiology and features of drug-induced headache. J. Neurol. (1999) 246:802-809. (Pubitemid 29467156)
4. SILBERSTEIN SD, LIU D: Drug overuse and rebound headache. Curr. Pain Headache Rep. (2002) 6:240-247.
5. DIENER HC: A personal view of the classification and definition of drug dependence headache. Cephalalgia (1993) 13(12):68-71.
6. SILBERSTEIN SD, LIPTON RB, SOLOMON S, MATHEW NT: Classification of daily and near-daily headaches: proposed revision to the IHS criteria. Headache (1994) 34:1-7. (Pubitemid 24038967)
7. KAUBE H, MAY A, DIENER HC, PFAFFENRATH V: Sumatriptan misuse in daily chronic headache. Br. Med. J. (1994) 308:1573.
8. LIMMROTH V, KATSARAVA S, FRITSCHE G, DIENER HC: Headache after frequent use of new 5-HT agonists zolmitriptan and naratriptan. Lancet (1999) 353:378. (Pubitemid 29088171)
9. DIENER HC, DAHLÖF C: Headache associated with chronic use of substances. In: The Headaches (2nd edn). Olesen J, Tfelt-Hansen P, Welch KMA (Eds), Lippincott Williams & Wilkins, Philadelphia (2000):871-878.
10. LIMMROTH V, KATSARAVA Z, FRITSCHE G, PRZYWARA S, DIENER HC: Clinical features of medication overuse headache following overuse of triptans and other headache drugs. Neurology (2002) 59:1011-1014.
11. RASMUSSEN BK, OLESEN J: Symptomatic and nonsymptomatic headaches in the general population. Neurology (1992) 42:1225-1231.
12. CASTILLO J, MUNOS P, GUITERA V, PASCUAL J: Epidemiology of chronic daily headache in the general population. Headache (1999) 39:190-196. (Pubitemid 29190083)
13. RASMUSSEN BK, JENSEN R, SCHROLL M et al.: Epidemiology of headache in a general population. A prevalence study. J. Clin. Epidemiol (1991) 44:1147-1157.
14. SANDRINI G, PROIETTI CECCHINI A, TASSORELLI C, NAPPI G: Diagnostic issues in chronic daily headache. Curr. Pain Headache Rep. (2001) 5:551-556.
15. MATHEW NT: Transformed migraine. Cephalalgia (1993) 13(Suppl. 12):78-83. (Pubitemid 23113011)
16. GUTZWILLER F, ZEMP E: Der Analgetikakonsum in der Bevölkerung und sozioökonomische Aspekte des Analgetikaabusus. In: Das Analgetikasyndrom. Mihatsch MJ (Ed.), Georg Thieme, Stuttgart (1986):197-205.
17. RASMUSSEN BK: Epidemiology of headache. Cephalalgia (1995) 15:45-68.
18. ROBINSON RG: Pain relief for headaches. Cam. Fam. Physician (1993) 39:867.
19. GRANELLA F, FARINA S, MALFERRARI G, MANZONI GC: Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia (1987) 7:15-19.
20. MICIELI G, MANZONI GC, GRANELLA F, MARTIGNONI E, MALFERRARI G, NAPPI G: Clinical and epidemiological observations on drug abuse in headache patients. In: Drug-induced headache. Diener HC, Wilkinson M (Eds), Springer, Berlin (1988):20-28.
21. GAIST D: Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data. Cephalalgia (1999) 19:735-761. (Pubitemid 29519984)
22. EVERS S, BAUER B, SUHR B, WIESER T, HUSSTEDT I: The epidemiology of sumatriptan abuse. In: Headache Treatment: Trial Methodology and New Drugs. Olesen J, Tfelt-Hansen P (Eds), Lippincott-Raven, Philadelphia (1997): 149-152.
23. DIENER HC: Medikamenteninduzierter Dauerkopfschmerz. In: Migräne: Aktuelle Aspekte eines altbekannten Leidens. Ensink FBM, Soyka D (Eds), Springer, Berlin (1994):463-475.
24. SRIKIATKHACHORN A, GOVITRAPONG P, LIMTHAVON C: Up-regulation of 5-HT2 serotonin receptor: a possible mechanism of transformed migraine. Headache (1994) 34:8-11.
25. WALLASCH TM: [Drug-induced headache]. Fortschr. Neurol. Psychiatr. (1992) 60:114-118. German.
26. SAWYNOK J: Pharmacological rationale for the clinical use of caffeine. Drugs (1995) 49(1): 37-50.
27. LIEBERMAN HR, WURTMAN RJ, EMDE GG, COVIELLA IL: The effects of caffeine and aspirin on mood and performance. J. Clin. Psychopharmacol. (1987) 7(5):315-320. (Pubitemid 18042931)
28. FEINSTEIN AR, HEINEMANN LA, DALESSIO D et al: Do caffeine-containing analgesics promote dependence? A review and evaluation. Clin. Pharmacol. Ther. (2000) 68:457-467.
29. FISHER MA, GLASS S: Butorphanol (Stadol): a study in problems of current drug information and control. Neurology (1997) 48:1156-1160. (Pubitemid 27240527)
30. HEINZ A, DENKE C, ERNST G: Medikamenteninduzierter Kopfschmerz- Mögliche Mechanismen der Abhängigkeitsentwicklung. Schmerz (1999) 13:304-314.
31. VERRI AP, PROIETTI CECCHINI A, GALLI C et al: Psychiatric comorbidity in chronic daily headache. Cephalalgia (1998) 18(Suppl. 21):45-49.
32. JUANG KD, WANG SJ, FUH JL, LU SR, SU TP: Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache (2000) 40(10):818-823.
33. RADAT F, SAKH D, LUTZ G, EL AMRANI M, FERRERI M, BOUSSER MG: Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache (1999) 39:477-480. (Pubitemid 29400298)
34. SINIATCHKIN M, RIABUS M, HASENBRING M: Coping styles of headache sufferers. Cephalalgia (1999) 19:165-173. (Pubitemid 29202148)
35. ROSEMEIER HP, SAUPE R, SIEVERDING M, ADLER M, POTTHOFF P: Medizinische Psychologie. Ferdinand Enke, Stuttgart (1987).
36. KRYMCHANTOWSKI AV, BARBOSA JS: Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia (2000) 20:107-113. (Pubitemid 32269517)
37. DIENER HC, HAAB J, PETERS C, RIED S, DICHGANS J, PILGRIM A: Subcutaneous sumatriptan in the treatment of headache during withdrawal from MOH. Headache (1991) 31:205-209.
38. MATHEW NT: Amelioration of ergotamine withdrawal with naproxen. Headache (1987) 27:130-133.
39. KATSARAVA Z, FRITSCHE G, MUESSIG M, DIENER HC, LIMMROTH V: Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology (2001) 57(9):1694-1698. (Pubitemid 33055491)
40. MATHEW NT, KURMAN R, PEREZ F: Drug induced refractory headache-clinical features and management. Headache (1990) 30:634-638.
41. BAUMGARTNER C, WESSELY P, BINGÖL C, MALY J, HOLZNER F: Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache (1989) 29:510-514. (Pubitemid 20318931)
42. PINI LA, CICERO AFG, SANDRINI M: Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia (2001) 21:878-883. (Pubitemid 34621510)
43. SUHR B, EVERS S, BAUER B, GRALOW I, GROTEMEYER KH, HUSSTEDT IW: Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia (1999) 19:44-49. (Pubitemid 29136851)
44. SCHNIDER P, AULL S, BAUMGARTNER C et al.: Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia (1996) 16:481-485. (Pubitemid 26373785)
45. DIENER HC, DICHGANS J, SCHOLZ E, GEISELHART S, GERBER WD, BILLE A: Analgesic-induced chronic headache: long-term results of withdrawal therapy. J. Neurol. (1989) 236:9-14. (Pubitemid 19113116)
46. FRITSCHE G, EBERL A, KATSARAVA Z, LIMMROTH V, DIENER HC: Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur. Neurol. (2001) 45:229-235. (Pubitemid 32521040)
47. VON KORFF M, GALER BS, STANG P: Chronic use of symptomatic headache medications. Pain (1995) 62:179-186.
48. PINI LA, BIGARELLI M, VITALE G, STERNIERI E: Headaches associated with chronic use of analgesics: a therapeutic approach. Headache (1996) 36:433-439. (Pubitemid 26260749)
49. DICHGANS J, DIENER HC, GERBERWD, VERSPOHL EJ, KUKIOLKA H, KLUCK M: Analgetika-induzierter Dauerkopfschmerz. Dtsch. Med. Wschr. (1984) 109:369-373. (Pubitemid 14161515)
50. TFELT-HANSEN P, KRABBE A: Ergotamine abuse. Do patients benefit from withdrawal? Cephalalgia (1981) 1:29-32. (Pubitemid 12230976)
51. TRIBL GG, SCHNIDER P, WÖBER C et al.: Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia (2001) 21:691-696. (Pubitemid 32762793)
52. KATSARAVA Z, LIMMROTH V, FINKE M, DIENER HC, FRITSCHE G: Rate and predictors for relapse in medication overuse headache: a one year prospective study. Neurology. In Press.